Related Experiment Video

Updated: Nov 9, 2025

Author Spotlight: Recent Advancements in Reoperative Foregut Surgery
04:14

Author Spotlight: Recent Advancements in Reoperative Foregut Surgery

Published on: September 22, 2023

693

Hiatal hernia and Cameron ulcer: an overlooked association in pediatric patients

Helena Moreira Silva1, Ricardo Küttner-Magalhães2, Rosa Lima1

  • 1Pediatric Gastroenterology, Hospital Santo António. Centro Hospitalar Universitário do Porto.

Revista Espanola De Enfermedades Digestivas
|April 13, 2021
PubMed

Insights

A ten-year-old boy with cerebral palsy and chronic lung disease experienced two years of iron deficiency anemia and vomiting. This case highlights the diagnostic challenges of iron deficiency anemia in complex pediatric patients.

Area of Science:

  • Pediatric Gastroenterology
  • Hematology
  • Neurology

Background:

  • A ten-year-old male with a complex medical history including cerebral palsy and chronic pulmonary disease.
  • The patient required mechanical cough assistance and nocturnal non-invasive ventilation.
  • This background highlights potential challenges in nutritional intake and gastrointestinal function.

Observation:

  • Presented with a two-year history of iron deficiency anemia (IDA).
  • Experienced occasional vomiting as a concurrent symptom.
  • Underlying conditions may impact nutrient absorption and contribute to anemia.

Findings:

  • Persistent iron deficiency anemia (IDA) over a two-year period.
  • Vomiting episodes occurred intermittently.
  • The etiology of IDA in this context requires thorough investigation beyond typical causes.

Implications:

  • Underscores the importance of considering complex comorbidities in the diagnosis of pediatric iron deficiency anemia.
  • Suggests a need for tailored diagnostic and management strategies in children with significant medical histories.
  • Highlights the potential link between gastrointestinal symptoms and IDA in neurologically impaired children.

More Related Videos

Laparoscopic Repair of Para-Esophageal Hernia Using Absorbable Biosynthetic Mesh10:52

Laparoscopic Repair of Para-Esophageal Hernia Using Absorbable Biosynthetic Mesh

Published on: September 11, 2021

5.5K
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors03:05

Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors

Published on: February 16, 2024

1.3K

Related Concept Videos

Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
409
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
294
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
845
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
216
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
794
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
357